Yifeng He

2.2k total citations · 1 hit paper
53 papers, 1.4k citations indexed

About

Yifeng He is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Yifeng He has authored 53 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Surgery and 13 papers in Oncology. Recurrent topics in Yifeng He's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Cancer-related molecular mechanisms research (4 papers). Yifeng He is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Cancer-related molecular mechanisms research (4 papers). Yifeng He collaborates with scholars based in China, United States and United Kingdom. Yifeng He's co-authors include Jian Zhou, Jia Fan, Alessandro Cucchetti, Matteo Cescon, Luciano De Carlis, Antonio Daniele Pinna, Stefano Di Sandro, Carlo Sposito, Vincenzo Mazzaferro and Andrea Lauterio and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Yifeng He

49 papers receiving 1.4k citations

Hit Papers

Metroticket 2.0 Model for Analysis of Competing Risks of ... 2017 2026 2020 2023 2017 100 200 300 400

Peers

Yifeng He
Joji Tani Japan
Gary J. Smith United States
Jack Leslie United Kingdom
Jun Luo China
Yifeng He
Citations per year, relative to Yifeng He Yifeng He (= 1×) peers Xiaoying Wang

Countries citing papers authored by Yifeng He

Since Specialization
Citations

This map shows the geographic impact of Yifeng He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifeng He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifeng He more than expected).

Fields of papers citing papers by Yifeng He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifeng He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifeng He. The network helps show where Yifeng He may publish in the future.

Co-authorship network of co-authors of Yifeng He

This figure shows the co-authorship network connecting the top 25 collaborators of Yifeng He. A scholar is included among the top collaborators of Yifeng He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifeng He. Yifeng He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Yifeng, Xiaowu Huang, Xiaoyong Huang, et al.. (2025). Graft PD-L1 as a predictive marker for rejection in PD-1 inhibitor therapy for recurrent liver tumors after transplant: A prospective pilot trial. Liver Transplantation. 32(2). 135–143.
2.
He, Yifeng, Feihan F. Dai, Zhenwei Wang, et al.. (2025). Integrated single-cell genomics, transcriptomics, and pathomics to identify potential biomarkers in muscle-invasive bladder cancer. Translational Andrology and Urology. 14(6). 1610–1630.
3.
Duan, Jianchun, et al.. (2025). Single-cell multi-omics and spatial transcriptomics reveal the transcriptional regulatory landscape of clear cell renal cell carcinoma. Translational Andrology and Urology. 14(10). 2953–2974.
4.
Mao, Rui, et al.. (2024). Unveiling new protein biomarkers and therapeutic targets for acne through integrated analysis of human plasma proteomics and genomics. Frontiers in Immunology. 15. 1452801–1452801. 1 indexed citations
5.
Xiao, Yong‐Sheng, et al.. (2024). Liver transplantation using an otherwise-wasted partial liver resection graft. Hepatobiliary & pancreatic diseases international. 24(1). 29–34.
6.
Huang, Ao, De‐Zhen Guo, Ying Sun, et al.. (2023). Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer. Hepatology International. 18(1). 254–264. 7 indexed citations
7.
He, Yifeng, et al.. (2021). Troglitazone inhibits hepatic oval cell proliferation by inducing cell cycle arrest through Hippo/YAP pathway regulation. Digestive and Liver Disease. 54(6). 791–799. 5 indexed citations
9.
Ma, Chi, Ke Xu, Lin Xu, et al.. (2018). Schisandrin B ameliorated chondrocytes inflammation and osteoarthritis via suppression of NF-κB and MAPK signal pathways. SHILAP Revista de lepidopterología. 2 indexed citations
10.
He, Yifeng, Lijun Xiang, Jian Zhang, et al.. (2017). Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells. World Journal of Gastroenterology. 23(34). 6242–6242. 19 indexed citations
11.
Mazzaferro, Vincenzo, Carlo Sposito, Jian Zhou, et al.. (2017). Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma. Gastroenterology. 154(1). 128–139. 407 indexed citations breakdown →
12.
He, Yifeng, Jun Wang, Ji Zhang, Fei Yuan, & Xiaoyi Ding. (2017). A prospective study on predicting local recurrence of giant cell tumour of bone by evaluating preoperative imaging features of the tumour around the knee joint. La radiologia medica. 122(7). 546–555. 13 indexed citations
13.
He, Yifeng, Juan Duan, Yong‐Guang Yang, et al.. (2017). Expression of Wnt3a in hepatocellular carcinoma and its effects on cell cycle and metastasis. International Journal of Oncology. 51(4). 1135–1145. 22 indexed citations
14.
Wang, Hong, Li Ren, Yifeng He, et al.. (2014). Association between cytochrome P450 2C9 gene polymorphisms and colorectal cancer susceptibility: evidence from 16 case–control studies. Tumor Biology. 35(5). 4317–4322. 5 indexed citations
15.
Huang, Cheng Zhi, Guangyu Ding, Chengyu Gu, et al.. (2012). Decreased Selenium-Binding Protein 1 Enhances Glutathione Peroxidase 1 Activity and Downregulates HIF-1α to Promote Hepatocellular Carcinoma Invasiveness. Clinical Cancer Research. 18(11). 3042–3053. 83 indexed citations
16.
Liu, Jianying, Jing Ding, Dong Lin, et al.. (2012). T2* MRI of minimal hepatic encephalopathy and cognitive correlates in vivo. Journal of Magnetic Resonance Imaging. 37(1). 179–186. 15 indexed citations
17.
Wang, Yisheng, Rui Cao, Hong Jin, et al.. (2011). Altered protein expression in serum from endometrial hyperplasia and carcinoma patients. Journal of Hematology & Oncology. 4(1). 15–15. 35 indexed citations
18.
Yu, Yanyan, Mingqi Liu, Guoquan Yan, et al.. (2011). Hydrazide-functionalized magnetic microspheres for the selective enrichment of digested tryptophan-containing peptides in serum. Talanta. 85(2). 1001–1006. 10 indexed citations
19.
Zhou, Jian, Zhen Shen, Yifeng He, Shan Zheng, & Jia Fan. (2010). The current status of pediatric liver transplantation in Mainland China. Pediatric Transplantation. 14(5). 575–582. 20 indexed citations
20.
Cui, Jiefeng, Yinkun Liu, Haijun Zhou, et al.. (2008). Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysis. World Journal of Gastroenterology. 14(8). 1257–1257. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026